Press release
Antisense and RNAi Therapeutics Market Emerging Trend, Top Companies, Industry Demand and Regional Analysis by 2027
The global market for Antisense and RNAi Therapeutics estimated at US$ 1.2 Billion in the year 2020, is projected to reach a revised size of US$ 1.9 Billion by 2027, growing at a CAGR of 6% over the period 2021-2027.Antisense and RNAi therapeutics are a new class of drugs that work by silencing parts of RNA through the use of short interfering RNAs (siRNAs) or microRNAs (miRNAs) that cause disease or induce degradation of target mRNAs. Reduce the translation of undesirable proteins using RNases.
(Get 15% Discount on Buying this Report)
A full report of Global Antisense and RNAi Therapeutics Market is available at: https://www.orionmarketreports.com/antisense-and-rnai-therapeutics-market/56620/
Market Segments
By Technology
• RNA Interference
• Antisense RNA
By Application
• Oncology
• Cardiovascular Diseases (CVDs)
• Respiratory Disorders
• Renal Diseases
• Neurodegenerative Disorders
• Genetic Disorders
• Infectious Diseases
• Other
By Route of Administration
• Pulmonary Delivery
• Intravenous Injections
• Intra-dermal Injections
• Intraperitoneal Injections
• Topical Delivery
• Other
Key Players
Some of the industry players in this market include Alnylam, Mirus Bio, Marina Biotech, Benitec Biopharma, RXi pharmaceuticals, Qiagen, Genzyme, and Moderna.
Scope of the Report
The research study analyzes the global Antisense and RNAi Therapeutics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Antisense and RNAi Therapeutics Market Report
1. What was the Antisense and RNAi Therapeutics Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).
2. What will be the CAGR of the Antisense and RNAi Therapeutics Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Antisense and RNAi Therapeutics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Antisense and RNAi Therapeutics market.
• The market share of the global Antisense and RNAi Therapeutics market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Antisense and RNAi Therapeutics market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Antisense and RNAi Therapeutics market.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antisense and RNAi Therapeutics Market Emerging Trend, Top Companies, Industry Demand and Regional Analysis by 2027 here
News-ID: 2301224 • Views: …
More Releases from Orion Market Reports
Sodium Cromoglicate API Market to Expand With Strong Development by 2031
The Sodium Cromoglicate API Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). Sodium Cromoglicate API (active pharmaceutical ingredient) is a type of medication used to treat allergic conditions such as hay fever, allergic conjunctivitis, and asthma. It works by stabilizing mast cells and preventing the release of allergic substances that cause symptoms like itching, redness, and swelling.
Sodium Cromoglicate API Market…
Soda Ash and Aluminium Trihydrate (ATH) Market Will Generate Record Revenue by 2 …
The Soda Ash and Aluminium Trihydrate (ATH) Market size is expected to grow at an annual average of CAGR 4% during the forecast period (2024-2031). Soda Ash, also known as sodium carbonate, is a white, odorless powder used in manufacturing glass, detergents, chemicals, and other industrial applications. Aluminium Trihydrate (ATH) is a white, non-toxic powder primarily used as a flame retardant in plastics, rubber, and textiles.
Soda Ash and Aluminium Trihydrate…
Single Crystal Silicon Wafers Market Provides Information on Historical Growth, …
The Single Crystal Silicon Wafers Market size is expected to grow at an annual average of CAGR 4% during the forecast period (2024-2031). Single crystal silicon wafers are thin, disc-shaped substrates made from a single crystal of silicon. They are a fundamental component in the semiconductor industry and serve as the foundation for manufacturing integrated circuits (ICs) and other microelectronic devices.
Single Crystal Silicon Wafers Market research analyzes the entire market,…
Silicone For Personal Care Market Growth Drivers, Developments, Technology And F …
The Silicone For Personal Care Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). Silicone for personal care refers to the use of silicone-based ingredients and formulations in various cosmetic and personal care products. Silicone compounds are valued in the personal care industry for their unique properties, including their smooth texture, excellent spreadability, water resistance, film-forming ability, and compatibility with skin…
More Releases for RNA
Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand.
Browse 156 Market Data Tables and 112 Figures spread through 175…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited.
Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring…
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year.
Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved…
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018!
Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led…
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion.
One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and…
